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Purpose: To investigate whether different mitochondrial DNA (mtDNA) haplogroups have a role on the development of
pseudoexfoliation glaucoma (PEG) in the Saudi Arab population.
Methods: The mtDNA regulatory region and coding regions comprising mtDNA haplogroup diagnostic polymorphisms
were sequenced in patients with PEG (n=94), healthy matched controls (free of PEG; n=112) and a healthy Saudi Arab
population group (n=810).
Results: The Eurasian haplogroup T and the Sub-Saharan African Haplogroup L2 confer susceptibility to PEG, whereas
the Eurasian haplogroup N1 was associated with reduced risk to develop PEG in the Saudi Arab population.
Conclusions: Mitochondrial haplogroups T and L2 may play a role in the development of PEG in the Saudi Arabian
population.
Pseudoexfoliation  (PEX)  syndrome  is  a  generalized
disorder of the extracellular matrix and currently represents
the most commonly identified specific cause of open-angle
glaucoma [1]. The pathologic process is characterized by the
chronic, stable accumulation of abnormal fibrillar aggregates
in the anterior segment and various extraocular tissues [2].
PEX  syndrome  is  frequently  associated  with
pseudoexfoliation glaucoma (PEG), which often has a more
aggressive clinical course and worse prognosis than the more
common primary open angle glaucoma (POAG) [3]. Early
studies  were  in  support  of  a  genetic  basis  for  PEX/PEG.
Furthermore,  pedigree  analysis  suggested  maternal
transmission,  raising  the  possibility  of  mitochondrial
inheritance  or  X-linked  inheritance  [4].  However,  studies
focused on functional candidate genes potentially involved in
PEX [5,6] found only one significant association between a
clusterin gene variant (CLU SNP rs2279590) and PEX in
German  patients  that  could  not  be  confirmed  in  Italian
patients. A latter genome-wide association study involving the
same  cohorts  identified  variants  at  contactin  associated
protein-like  2  gene  (CNTNAP2)  associated  with  PEX  but
again only in German patients [6]. It seems that, until now,
the only consistent association between gene polymorphisms
and  PEX/PEG  is  that  with  relatively  common  sequence
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variants in the Lysyl oxidase-like 1 (LOXL1) autosomal gene.
This  association  was  first  detected  in  Nordic  European
samples [7] and, since then, confirmed in samples with broad
ethnic  diversity  [6,8-10].  However,  the  few  gene
polymorphisms  found  associated  with  PEX/PEG  cannot
explain the population incidence of these syndromes. It seems
that  the  hereditary  susceptibility  detected  could  be  better
explained as the result of multigenic combinations in which
mtDNA polymorphisms might also participate. In fact, in a
recent study, it was found that mitochondrial haplogroup U
was associated with a reduced risk to develop exfoliation
glaucoma in the German population [11].
In Saudi Arabia about 10% of glaucoma patients are PEG
[10] and in the eastern region of the Arabian Peninsula PEX
accounts for 77% of all cases of open-angle glaucoma [12].
Similar to almost all non-African populations tested thus
far, the “G” allele of both rs1048661 and rs3825942 SNPs
were  associated  with  the  risk  of  PEG  in  the  Saudi  Arab
population  [10].  There  are  also  studies  of  the  effect  of
mitochondrial gene mutations and polymorphisms on PEG in
Saudi  Arabia.  However,  there  was  little  evidence  that
potentially  pathological  mtDNA  mutations  played  a
significant role in PEG in Saudi Arabia [13]. In another study,
assessing the role of mitochondrial haplogroups in glaucoma,
also in the Saudi Arabian population, it was found that patients
with haplotypes belonging to the preHV-1 (now named R0a)
haplogroup were at higher risk of developing primary angle-
closure  glaucoma  (PACG),  but  it  could  not  detect  any
significant  difference  in  haplogroup  frequencies  between
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543PEG patients and controls [14]. However, the small sample
size for PEG (n=29) in that study [14], and its subdivision into
different  mtDNA  haplogroups,  was  clearly  insufficient  to
perform robust statistical analysis. The aim of the present
study was to assess the role of mtDNA haplogroups in PEG
among  Saudi  patients.  This  aim  will  be  achieved  by
comparing the mtDNA haplogroup frequencies in a PEG-
patient cohort (n=94) with those of matched healthy controls
(n=112) and with a large healthy sample (n=810) taken for
population genetics purposes.
METHODS
Study population: This study adheres to the tenets of the
Declaration  of  Helsinki  and  all  participants  signed  an
informed consent. The study was approved by the College of
Medicine,  King  Saud  University,  Riyadh,  Saudi  Arabia
ethical  committee  (proposal  number  08–657).  All  study
subjects  were  self  identified  as  Saudi  Arabian  ethnicity.
Subjects with clinically diagnosed PEG (n=94) and age and
sex healthy matched controls, HMC, (n=112) were recruited
into  the  study  at  King  Abdulaziz  University  Hospital  in
Riyadh, Saudi Arabia.
All  participants  underwent  a  standardized  detailed
ophthalmic  examination,  which  included  visual  acuity,
measurement  of  intraocular  pressure  (IOP)  by  Goldmann
applanation tonometry, slit lamp biomicroscopy, gonioscopy,
and detailed examination of the lens and fundus. Patients with
PEG  were  defined  as  those  with  clinical  evidence  of
exfoliation  material  on  the  pupil  margin  or  anterior  lens
surface and the presence of glaucomatous optic neuropathy
with associated visual field defect in one or both eyes and
documented  IOP  >22  mmHg  in  either  eye.  Saudi  Arab
subjects  (n=112)  with  normal  anterior  segment  and  optic
nerve examination, IOP <18 mmHg, and no clinical signs of
exfoliation were recruited as control subjects.
A third large sample (n=810) of healthy Saudi Arabs
(HSA), representing all five major Saudi Arabian provinces
and were recruited previously for population genetics studies,
was used for statistical comparisons. All individuals of this
group  were  Saudi  Arabs  who  reported  no  symptomatic
metabolic,  genetic,  ocular  disorders  or  any  ophthalmic
problem  on  an  extensive  questionnaire  regarding  family
history, past medical problems, and current health. For those
controls, their mother’s ancestral origin was established as a
Saudi. The mtDNA haplogroup assignation for 552 subjects
of this sample has been already published [15].
DNA extraction: Five ml of peripheral blood were collected
in EDTA tubes from all participating individuals. DNA was
extracted using the illustra blood genomicPrep Mini Spin Kit
from GE Healthcare (Buckinhamshire, UK), and stored at –
20 °C in aliquots until required.
Mitochondrial  haplogroup  assortment:  All  samples  were
amplified and sequenced for the mtDNA regulatory region
hypervariable segments (HVSs) I and II using primers pairs
L15996/H16401  and  L16340/H408,  respectively,  as
previously  described  [16].  Haplotypes  were  tentatively
assorted into haplogroups according to their HVS diagnostic
positions.  This  assortment  was  further  confirmed,  when
necessary,  by  the  analysis  of  coding-region  diagnostic
haplogroup  polymorphisms  (Table  1),  following  the  most
recent mtDNA haplogroup nomenclature [17]. To detect these
polymorphisms, a fragment spanning the diagnostic position
was amplified and sequenced using any of the 32 overlapping
pairs of primers that cover the whole mtDNA genome, and the
PCR and sequencing conditions previously published for each
of them [16]. To keep adequate haplogroup sub-sample sizes
within  cohorts,  mtDNA  haplogroups  were  collapsed  into
larger  haplogroup  identities  following  a  phylogenetic
criterion [17].
Data analysis: Global comparison of haplogroup frequencies
among patient and control cohorts were performed by analysis
of molecular variance (AMOVA) among groups. Differences
between groups were tested by pair-wise exact tests of sample
differentiation [18,19], based also on haplogroup frequencies.
In both cases the Arlequin 3.11 package was used. χ2 or Fisher
exact tests were applied to investigate the association between
having  a  certain  haplogroup  and  the  occurrence  of  PEG
compared to controls.
RESULTS
Table 1 presents haplogroup frequencies in the PEG and HMC
cohorts  and  in  the  general  Saudi  Arab  population  (HSA)
sample. Table 1 showed that haplogroups R0a and J were
particularly abundant in the three groups tested and this is
previously  known  characteristic  of  the  Arab  population
mtDNA Haplogrouping [15,20]. The prevalence of these two
haplogroups combined was 41%, 35%, and 39% for PEG,
HMC and HSA groups, respectively. In comparison to the
HSA  group,  the  lack  of  the  Eurasian  haplogroup  N1
representatives, the low frequency of the Eurasian haplogroup
U and the high frequency of the Eurasian haplogroup T and
the sub-Saharan African haplogroup L2 were distinctive of
the PEG cohort. The high frequency of haplogroup U was the
most outstanding characteristic of the HMC cohort (Table 1).
Congruently, global AMOVA analysis showed a significant
haplogroup  frequency  heterogeneity  among  groups
(p=0.023). Pair-wise exact tests between cohorts showed that
this  statistical  heterogeneity  is  mainly  due  to  particular
differences between PEG versus HMC (p=0.016) and PEG
versus  HSA  group  (p=0.027)  as  haplogroup  differences
between  both  control  groups  did  not  reach  statistical
significance (p=0.178). χ2 or two tailed Fisher exact tests
analysis of haplogroup frequencies in PEG patients versus
HMC  group  indicate  that  haplogroups  T  and  L2  were  in
significant  excess  in  PEG  patients  compared  to  HMC
(p=0.025 and p=0.045, respectively). When we performed the
same analysis for the PEG patients versus HSA group, we
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545noticed that haplogroups T and L2 were more abundant in the
PEG patients compared to the HSA groups. Statistically, this
abundance was significant for the L2 haplogroup (p=0.008)
and  near  significance  for  the  T  haplogroup  (p=0.065).
Furthermore,  the  lack  of  Eurasian  haplogroup  N1
representatives in PEG patients, significantly contrasts with
its  moderate  presence  in  both  HMC  (p=0.008)  and  HSA
(p=0.004) control groups. However, the respective higher and
lower frequencies found in HMC and PEG cohorts for the
Eurasian haplogroup U was near significance, but did not
reach statistical significance (p=0.073). These data could be
interpreted as that haplogroups T and L2 associated with the
risk  of  developing  PEG  in  the  Saudi  population,  while
mitochondrial  haplogroup  N1  could  be  a  protective  or
associated with reduced risk of developing PEG.
DISCUSSION
Despite  early  genetic  studies  indicating  that  maternal
transmission  could  play  an  important  role  in  PEX
susceptibility [4], few studies have been performed to test the
effect of mitochondrial background on PEX/PEG syndromes.
In the present study, we found that carriers of the Eurasian
mtDNA  haplogroups  T  and  the  sub-Saharan  African
haplogroup L2 were at higher risk of developing PEG. In
contrast,  carriers  of  the  Eurasian  haplogroup  N1  were  at
reduced risk to develop PEG.
Previously, we investigated the frequencies of mtDNA
haplogroups in a 29 diagnosed PEG Saudi subjects [14]. Here
we attempted to test whether the associations found here still
hold when a composite PEG (cPEG) cohort was compared
with both present work control groups (HMC and HSA). Since
haplogroup N1 was also absent in the previously published
PEG  cohort,  statistical  significance  rises  when  the  cPEG
cohort was tested against HMC (p=0.003) and against HSA
(p=0.001). However in the test for haplogroup T involving
cPEG versus HMC, although still significant (p=0.039), a
lower  p-value  than  the  one  found  in  the  present  study
(p=0.025) was obtained. Again, testing cPEG vs HSA lacked
statistical  significance  (p=0.105).  Similar  results  were
obtained for comparisons involving haplogroup L2, while the
test  cPEG  versus  HSA  was  near  significance  (p=0.066)
significance disappears in the test involving HMC (p=0.140).
Recently,  mtDNA  haplogroup  U  was  significantly
associated  with  a  reduced  risk  of  developing  exfoliation
glaucoma in the German population, whereas haplogroup T
was slightly over-represented in the glaucoma cohort when
compared to controls. However, these differences did not
reach statistical significance [11]. It is inquisitive that the
trends for haplogroups T and U are the same in the Saudi Arab
and the German populations with, respectively, higher and
lower  frequencies  in  PEG  patients  compared  to  their
respective  matched  controls.  However,  whereas  only
haplogroup T based comparison reached significance in the
Saudi Arabian population, haplogroup U comparison reach
significance among Germans. N1 and L2 haplogroups could
not  be  tested  in  the  German  population  because,  N1
haplogroup is very scarce in Europe and L2 is mainly confined
to the African continent.
Most probably the Eurasian haplogroups T and U have,
respectively,  mild  risk  and  protective  effects  in  the
development of PEG. Additionally, carriers of the Eurasian
haplogroup N1, at least among the Saudi Arabian population,
seem to be at significant reduced risk to PEG whereas those
with the sub-Saharan African haplogroup L2 are associated
with PEG susceptibility. Although all the coding diagnostic
variants of haplogroups L2 and U are synonymous, there is a
nonsynonymous  transition,  A13780T,  in  the  root  of
haplogroup N1 that changes an Ile amino-acid to Val in the
mitochondrial NADH dehydrogenase subunit 5. There is also
a  nonsynonymous  transition,  A4917G  at  the  root  of
haplogroup T that changes an Asn amino-acid to Asp in the
mitochondrial NADH dehydrogenase subunit 2. However, the
fact that these variants are widely distributed in the healthy
population, weaken the hypothesis of a direct involvement of
these  mitochondrial  variants  in  the  development  of  PEG.
Nevertheless, we could not ignore a possible interaction with
the nuclear-genome which may influence the development of
PEG. In addition to geographic mtDNA haplogroup frequency
differences, population structure might mask or enhance these
types  of  associations.  In  fact,  the  mtDNA  haplogroup
associations with PEG found in this study were stronger when
the PEG cohort was compared to the matched healthy controls
(free of PEG by examination) than when it was compared to
the Saudi Arabian global sample (HSA group).
In conclusion, we have found that T and L2 haplogroups
confer  susceptibility  to  PEG  whereas  N1  haplogroup  is
associated with a reduced risk to develop this illness. To know
whether these associations are consistent in other geographic
areas,  sample  sizes  should  be  adequate  to  the  relative
frequencies of the mtDNA haplogroups involved in them.
Additionally,  the  incorporation  in  the  genome-wide
association studies of the mtDNA SNPs that define the most
important haplogroups worldwide would help to detect those
nuclear-mitochondrial  gene  interactions  that  predispose  or
protect to illnesses with polygenic diseases such as PEG.
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